Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Ossenkoppele

Showing results (121-130 of 152) with videos related to

Pageof 16
Sort By:
Bone Marrow Transplantation|August 1, 1996
G-CSF (filgrastim)-stimulated whole blood kept unprocessed at 4 degrees C does support a BEAM-like regimen in bad-risk lymphomaG J Ossenkoppele, G J Schuurhuis, A R Jonkhoff, et al.
Leukemia|November 15, 2011
Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up resultsP D le Coutre, F J Giles, A Hochhaus, et al.
Cancer|April 15, 1993
Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosisP C de Bruin, A L Noorduyn, P van der Valk, et al.
European Journal of Nuclear Medicine|January 1, 1992
Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-cameraA van Lingen, P C Huijgens, F C Visser, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|July 9, 2008
Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemiaC J Hess, N Ameziane, G J Schuurhuis, et al.
International Journal of Laboratory Hematology|April 5, 2012
Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemiaM Terwijn, A Kelder, A N Snel, et al.
Leukemia|August 18, 1999
A randomized study of granulocyte colony-stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group. Dutch-Belgian Hemato-Oncology Cooperative GroupG J Ossenkoppele, B van der Holt, G E Verhoef, et al.
Leukemia|July 17, 1998
Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual diseaseT Szczepański, A W Langerak, I L Wolvers-Tettero, et al.
Experimental Hematology|November 1, 1996
The role of BCL-2 and bax protein in monocyte-mediated apoptosis in human leukemic cell linesM C Legdeur, P M Bontje, G J Ossenkoppele, et al.
Annals of Hematology|June 1, 1993
Acute lymphoblastic leukaemia in adults: immunological subtypes and clinical features at presentationM B van't Veer, W L van Putten, L F Verdonck, et al.
Pageof 16

Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
Bone Marrow Transplantation|August 1, 1996
G-CSF (filgrastim)-stimulated whole blood kept unprocessed at 4 degrees C does support a BEAM-like regimen in bad-risk lymphomaG J Ossenkoppele, G J Schuurhuis, A R Jonkhoff, et al.
Leukemia|November 15, 2011
Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up resultsP D le Coutre, F J Giles, A Hochhaus, et al.
Cancer|April 15, 1993
Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosisP C de Bruin, A L Noorduyn, P van der Valk, et al.
European Journal of Nuclear Medicine|January 1, 1992
Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-cameraA van Lingen, P C Huijgens, F C Visser, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|July 9, 2008
Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemiaC J Hess, N Ameziane, G J Schuurhuis, et al.
International Journal of Laboratory Hematology|April 5, 2012
Minimal residual disease detection defined as the malignant fraction of the total primitive stem cell compartment offers additional prognostic information in acute myeloid leukaemiaM Terwijn, A Kelder, A N Snel, et al.
Leukemia|August 18, 1999
A randomized study of granulocyte colony-stimulating factor applied during and after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group. Dutch-Belgian Hemato-Oncology Cooperative GroupG J Ossenkoppele, B van der Holt, G E Verhoef, et al.
Leukemia|July 17, 1998
Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual diseaseT Szczepański, A W Langerak, I L Wolvers-Tettero, et al.
Experimental Hematology|November 1, 1996
The role of BCL-2 and bax protein in monocyte-mediated apoptosis in human leukemic cell linesM C Legdeur, P M Bontje, G J Ossenkoppele, et al.
Annals of Hematology|June 1, 1993
Acute lymphoblastic leukaemia in adults: immunological subtypes and clinical features at presentationM B van't Veer, W L van Putten, L F Verdonck, et al.
Pageof 16